Beximco Pharmaceuticals (DHA:BXPHARMA) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Beximco Pharmaceuticals's Free Cash Flow for the three months ended in Dec. 2023 was BDT0 Mil. Beximco Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was BDT10,904 Mil. Therefore, Beximco Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Beximco Pharmaceuticals's current FCF Yield % is 6.32%.

The historical rank and industry rank for Beximco Pharmaceuticals's FCF Margin % or its related term are showing as below:

DHA:BXPHARMA' s FCF Margin % Range Over the Past 10 Years
Min: -18.28 Med: -3.17 Max: 12.76
Current: 11.07

During the past 13 years, the highest FCF Margin % of Beximco Pharmaceuticals was 12.76%. The lowest was -18.28%. And the median was -3.17%.

DHA:BXPHARMA's FCF Margin % is ranked better than
77.85% of 1025 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs DHA:BXPHARMA: 11.07

Beximco Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Beximco Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals FCF Margin % Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

-6.95

12.76

11.75

6.56

8.59

Beximco Pharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															0.02	10.09	15.00	9.38	-

Competitive Comparison of Beximco Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beximco Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's FCF Margin % falls into.

Beximco Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Beximco Pharmaceuticals's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	3374.759	/	39266.662
	=	8.59 %

Beximco Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	10904.211
	=	0.00 %

Beximco Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » FCF Margin %

Traded in Other Exchanges

BXP:UK R2WA:Germany

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines